TotalMarketCap

Market cap

$58.975 B

$309.05 -0.24%

Close of 5 Oct 2026

As of 5 Oct 2026, Cencora (COR) has a market capitalization of $59.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$321.3B

#9 by revenue

Earnings

$1.55B

#278 by earnings

Shares outstanding

190,827,165

Latest filing cover page

P/E ratio

37.9

Cap ÷ net income

Other Pharmaceuticals, ranked by market cap

All 10 →
  1. #1McKessonMCK$105.2B
  2. #2CencoraCOR$59.0B
  3. #3Cardinal HealthCAH$52.9B
  4. #4HerbalifeHLF$1.32B
  5. #5Nu Skin EnterprisesNUS$224.4M

What if Cencora were worth as much as…

Open the what-if tool →

Or at a round number

Where these numbers come from

Share counts and financials for Cencora are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 6 Oct 2026. Read the methodology.